Results 141 to 150 of about 7,277 (214)

Contraceptive use in France in 2012 and 2022: a descriptive analysis of two repeated nationwide cross-sectional studies. [PDF]

Lancet Reg Health Eur
Poncet L, Roland N, Fortuna R, Hider-Mlynarz K, Dray-Spira R, Weill A, Zureik M.   +6 more
europepmc   +1 more source

Adverse Physical Consequences of Perinatal E-cigarette Use by Pregnant Mothers on Their Offspring: A Scoping Review. [PDF]

Cureus
Ramesh Babu YS, Kapil AM, Gunthner AR, Rajan RV, Triyono A, Schafer A, Chen AM, Maisel KM, Gogerdchian H, Copper J, Costin JM.   +10 more
europepmc   +1 more source

Use of Intrauterine Device and Risk of Invasive Cervical Cancer [PDF]

, 2017
NEGRI, EVA, PARAZZINI, FABIO, VECCHIA, CARLO LA   +2 more
core  

Retention of a Copper T380A Intrauterine Device for 29 Years in a 64-Year-Old Female With Postmenopausal Bleeding. [PDF]

Cureus
Glickman M, Cohen J, Perumareddi P.
europepmc   +1 more source

Intrauterine device migration into the bladder with urolithiasis: A case report. [PDF]

Int J Surg Case Rep
Jaziri Y, Saidani B, Saadi A, Haroun A, Chakroun M, Ben Slama R.   +5 more
europepmc   +1 more source

Virtual Reality for Analgesia During Intrauterine Device Insertion: Randomized Controlled Trial.

JMIR Serious Games
Higgins C, Zecena Morales C, Hocking J, Tyson K, Leung C, Larmour L, Leong P, Vollenhoven B.   +7 more
europepmc   +1 more source

Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone. [PDF]

Front Endocrinol (Lausanne)
Niu SY, Yi YC, Shih YH, Tseng JJ.
europepmc   +1 more source

Copper seven intrauterine device. Clinical experience.

Minnesota medicine, 1973
openaire   +1 more source

A Levonorgestrel-Releasing Intrauterine Device in the Right Upper Quadrant: A Case Report. [PDF]

Cureus
Cohen JM, Fegale SL, Phan T, Samones E, Savino P.   +4 more
europepmc   +1 more source